Company sells equity at €0.54 per share via managers Nomura and Nordea
By Devika Patel
Knoxville, Tenn., March 11 - BioTie Therapies Corp. said it settled a private placement of shares. The deal raised €26.99 million.
The company sold 49,977,084 shares at €0.54 each.
Nomura Code Securities Ltd. and Nordea Bank Finland plc were lead managers.
Biotie, based in Turku, Finland, is a biotech company focused on treatments for dependence disorders like alcoholism and pathological gambling, as well as inflammatory diseases and thrombosis.
| Issuer: | BioTie Therapies Corp.
|
| Issue: | Ordinary shares
|
| Amount: | €26,987,625
|
| Shares: | 49,977,084
|
| Price: | €0.54
|
| Warrants: | No
|
| Managers: | Nomura Code Securities Ltd. and Nordea Bank Finland plc
|
| Settlement date: | March 11
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
